Home NDC 51079-821 Levetiracetam
Product NDC 51079-821
11-digit product format 510790821
Labeler code 51079
Product ID 51079-821_4369847b-77af-cd07-e063-6394a90a9251
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name levetiracetam
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Mylan Institutional Inc.
Application ANDA076919
Marketing category ANDA
Marketing start 2008-11-04
Substance LEVETIRACETAM
Active strength 500 mg/1
Pharmacologic classes Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076919-001 LEVETIRACETAM LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 A076919-002 LEVETIRACETAM LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 A076919-003 LEVETIRACETAM LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076919-002 LEVETIRACETAM 500MG TABLET / ORAL AB 2008-11-04 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076919-003 LEVETIRACETAM 750MG TABLET / ORAL AB 2008-11-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076919-001 LEVETIRACETAM 250MG TABLET / ORAL 2008-11-04 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 101 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Levetiracetam
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LEVETIRACETAM 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 44YRR34555 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 311289 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51079-821-01 Levetiracetam 1 in 1 BLISTER PACK TABLET, FILM COATED 1 17 51079-821-20 Levetiracetam 100 in 1 CARTON TABLET, FILM COATED 100 17
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LEVETIRACETAM ACTIVE INGREDIENT 44YRR34555 LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 LEVETIRACETAM ACTIVE MOIETY 44YRR34555 LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 POLYDEXTROSE INACTIVE INGREDIENT VH2XOU12IE LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 POVIDONES INACTIVE INGREDIENT FZ989GH94E LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 LEVETIRACETAM TABLET, FILM COATED [CARDINAL HEALTH] 9 LEVETIRACETAM ACTIVE INGREDIENT 44YRR34555 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 LEVETIRACETAM ACTIVE MOIETY 44YRR34555 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 POLYDEXTROSE INACTIVE INGREDIENT VH2XOU12IE LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 POVIDONES INACTIVE INGREDIENT FZ989GH94E LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51079-821 LEVETIRACETAM TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] 15 Current NDC, Legacy NDC, 2 package rows 20211224_08e1bfea-7f3f-42d9-823d-f75080e664ff.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 51079-821-01 51079082101 1 in 1 BLISTER PACK Historical 51079-821-20 51079082120 100 BLISTER PACK in 1 CARTON (51079-821-20) / 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-821-01) 100 blister pack 2008-11-04 0000-00-00 No No Current